Does perimenopause cause unpredictable or heavy uterine bleeding that lowers ferritin?

The perimenopausal transition is a period of significant physiological change that frequently manifests as changes in uterine bleeding patterns. For many women, this includes a transition from regular cycles to unpredictable or heavy menstrual bleeding, which has a direct and measurable impact on systemic iron stores.

Mechanisms of bleeding and iron loss

Perimenopause is characterized by declining ovarian reserve and unstable hormone production. These changes lead to specific physiological outcomes:

• Hormonal instability: Fluctuating estrogen levels without the regular, counterbalancing effect of progesterone (often due to anovulatory cycles) cause the uterine lining (endometrium) to thicken excessively. This "unopposed estrogen" results in unpredictable shedding and heavy flow.
• Structural factors: The prevalence of uterine fibroids and endometrial polyps increases during this stage. In clinical cohorts, approximately 72% of perimenopausal abnormal uterine bleeding cases are linked to these structural causes, with fibroids accounting for nearly 40%.
• Direct iron depletion: Heavy menstrual bleeding (HMB) is the primary driver of iron loss in this population. Chronic blood loss can easily exceed the body's dietary iron absorption capacity. Research indicates that menstrual blood loss is the most significant predictor of total body iron stores, often outweighing the influence of age or diet.

Clinical evidence and markers

The relationship between bleeding and iron status is well-documented through clinical biomarkers:

• Ferritin as a key indicator: Serum ferritin is the most sensitive marker for assessing total body iron stores. Studies show a strong negative correlation between the volume of menstrual blood loss and ferritin levels.
• Prevalence of deficiency: Among women experiencing HMB, the prevalence of iron deficiency (typically defined as ferritin <30 μg/L) ranges from 40% to over 68%.
• Response to intervention: Clinical trials demonstrate that reducing menstrual flow—for example, through medical interventions like the levonorgestrel-releasing intrauterine device—leads to significant increases in ferritin (averaging nearly 20 ng/mL), confirming the causal link.

Bottom line

Strong scientific evidence supports the claim that perimenopause causes unpredictable or heavy uterine bleeding through hormonal and structural changes. This increased blood loss is a primary cause of iron depletion and low serum ferritin in women during the menopausal transition.